These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1419 related items for PubMed ID: 15376301

  • 1. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ, Yoo HY.
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [Abstract] [Full Text] [Related]

  • 2. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [Abstract] [Full Text] [Related]

  • 3. Survival after pediatric liver transplantation: why does living donation offer an advantage?
    Austin MT, Feurer ID, Chari RS, Gorden DL, Wright JK, Pinson CW.
    Arch Surg; 2005 May; 140(5):465-70; discussion 470-1. PubMed ID: 15897442
    [Abstract] [Full Text] [Related]

  • 4. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

  • 6. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 27; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 7. UNOS Liver Registry: ten year survivals.
    Waki K.
    Clin Transpl; 2006 Jul 27; ():29-39. PubMed ID: 18368704
    [Abstract] [Full Text] [Related]

  • 8. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States.
    Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R.
    Liver Transpl; 2004 Mar 27; 10(3):340-6. PubMed ID: 15004758
    [Abstract] [Full Text] [Related]

  • 9. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2004 Oct 27; 10(10):1248-55. PubMed ID: 15376308
    [Abstract] [Full Text] [Related]

  • 10. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
    Lawal A, Ghobrial R, Te H, Artinian L, Eastwood D, Schiano TD.
    Transplant Proc; 2007 Dec 27; 39(10):3261-5. PubMed ID: 18089367
    [Abstract] [Full Text] [Related]

  • 11. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S.
    Liver Transpl; 2007 Oct 27; 13(10):1405-13. PubMed ID: 17902126
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database.
    Bunnapradist S, Chung P, Peng A, Hong A, Chung P, Lee B, Fukami S, Takemoto SK, Singh AK.
    Transplantation; 2006 Sep 15; 82(5):612-8. PubMed ID: 16969282
    [Abstract] [Full Text] [Related]

  • 13. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.
    Smith CM, Davies DB, McBride MA.
    Clin Transpl; 1999 Sep 15; ():23-34. PubMed ID: 11038623
    [Abstract] [Full Text] [Related]

  • 14. Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients.
    Shen B, Chen B, Zhang W, Mao H, Shen C, Deng X, Zhan X, Chen H.
    Liver Transpl; 2009 Nov 15; 15(11):1473-80. PubMed ID: 19877254
    [Abstract] [Full Text] [Related]

  • 15. Is recurrent hepatitis C worse with living donors?
    Kuo A, Terrault NA.
    Curr Opin Organ Transplant; 2009 Jun 15; 14(3):240-4. PubMed ID: 19395968
    [Abstract] [Full Text] [Related]

  • 16. Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models.
    Durand F, Belghiti J, Troisi R, Boillot O, Gadano A, Francoz C, de Hemptinne B, Mallet A, Valla D, Golmard JL.
    Liver Transpl; 2006 Feb 15; 12(2):231-9. PubMed ID: 16447208
    [Abstract] [Full Text] [Related]

  • 17. Longterm outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases.
    Hong JC, Yersiz H, Farmer DG, Duffy JP, Ghobrial RM, Nonthasoot B, Collins TE, Hiatt JR, Busuttil RW.
    J Am Coll Surg; 2009 May 15; 208(5):682-9; discusion 689-91. PubMed ID: 19476815
    [Abstract] [Full Text] [Related]

  • 18. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB, A2ALL Study Group.
    Liver Transpl; 2007 Jan 15; 13(1):122-9. PubMed ID: 17192908
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.
    Transplantation; 2006 Feb 15; 81(3):350-4. PubMed ID: 16477219
    [Abstract] [Full Text] [Related]

  • 20. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP.
    Liver Transpl; 2012 Feb 15; 18(2):160-5. PubMed ID: 22006378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.